Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
about
Autophagy induced by AXL receptor tyrosine kinase alleviates acute liver injury via inhibition of NLRP3 inflammasome activation in mice.TAM receptor tyrosine kinase function and the immunopathology of liver disease.Chronic hepatitis C virus infection and pathogenesis of hepatocellular carcinoma.Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis.Hepatic stellate cells as key target in liver fibrosis.Spotlight on the three main hepatic fibrogenic cells in HCV-infected patients: Multiple immunofluorescence and ultrastructure study.Gas6 Promotes Oligodendrogenesis and Myelination in the Adult Central Nervous System and After Lysolecithin-Induced DemyelinationA new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivoThe non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis.Should vitamin K be supplemented instead of antagonised in patients with idiopathic pulmonary fibrosis?Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease.Protective Effects of Pterostilbene Against Myocardial Ischemia/Reperfusion Injury in Rats.Gas6 as a putative noninvasive biomarker of hepatic fibrosis.Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review
P2860
Q38409398-1D8E4D1C-317B-488C-83F6-667A526D99A2Q38729745-16312FBC-E568-4AC8-9441-27CEC65373C9Q38980732-1461617B-620F-4C4A-A795-11F08D2A8FCCQ39084507-F0E8BE93-AEF4-4CBA-944C-854D741F7138Q40193396-C21A3159-0FD2-4167-BA3F-F5CF96E924D7Q40200602-34E64727-F3C3-4E0A-AA4A-B232EB977435Q40615522-66065214-6D9E-42CE-9D3C-F158FC16AA8AQ41121864-F8EBB3B5-6332-4F2D-B3DD-988EF250C92CQ42578817-A490A219-C938-414E-834B-96F11D4862DBQ47133471-B8963165-D899-4368-AA61-12415305F988Q47230370-C52B49AE-7B12-4A8A-A7EF-83FF9157592FQ47565355-018CC9A0-3B9B-40BE-B440-2A38C7718400Q48880463-EDF9A8B8-2D63-497D-8507-90E89E9B51F6Q51281899-AA9F39C7-1FA4-4C16-9CEF-6896F6D141B3Q54116750-9BCCD396-6FBF-4E76-B485-329DDB0D8384Q57066901-61B4ACBB-0B4A-4C7E-8066-F89FE72A7DD4
P2860
Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@ast
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@en
type
label
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@ast
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@en
prefLabel
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@ast
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@en
P2093
P2860
P50
P1476
Gas6/Axl pathway is activated ...... ic stellate cell inactivation.
@en
P2093
Anghara Menéndez
Carmen García-Ruiz
Cristina Bárcena
Joan Caballeria
Leonel Joannas
Milica Stefanovic
P2860
P304
P356
10.1016/J.JHEP.2015.04.013
P50
P577
2015-04-20T00:00:00Z